禽霍乱新型疫苗的研究进展

doi:10.11843/j.issn.0366-6964.2018.11.003

摘要/Abstract

摘要：

禽霍乱是一种禽类的接触性、系统性传染病，发病率和致死率高，给养禽业发展造成巨大的经济损失。随着病原菌抗生素耐药问题的日益严重，疫苗应成为防控该病的主要手段。目前应用于我国家禽产业的疫苗包括传统的灭活苗和弱毒苗，但它们具有一定缺陷，如油乳灭活苗交叉保护差；自然弱毒株遗传背景不明，毒力时而返强等。因此，研制安全、高效、制备方便的新型疫苗是迫切需求，也是未来研究的趋势。本文针对近年来开发的减毒疫苗、亚单位疫苗、DNA疫苗等多种禽霍乱新型疫苗进行综述，为研制更安全有效的疫苗提供一定的参考。

Abstract:

Fowl cholera is a contagious and systemic disease of poultry worldwide caused by the species Pasteurella multocida, causing high morbidity and mortality and severe economic losses to poultry industry. As the prevalence of multidrug resistance among Pasteurella multocida isolates has continuously increased, immunization methods, the most potent preventive measure should become the main tool for controlling the disease. The current commercial vaccines contain traditional inactivated vaccine and empirically derived live vaccines, however, they exhibit some defects. The former provides limited cross-protection against heterologous serotypes; genetic background of the latter is not known and reversion to virulence occurs. Thus, novel vaccines against fowl cholera are urgently required. Here, we summarized the development of a variety of new-type vaccines against fowl cholera including attenuated live vaccine, subunit vaccine and DNA vaccine, to promote the exploration of new vaccines with safety and effective protection.

中图分类号:

S852.612

梁圣, 赵新新, 程安春. 禽霍乱新型疫苗的研究进展[J]. 畜牧兽医学报, 2018, 49(11): 2317-2325.

LIANG Sheng, ZHAO Xin-xin, CHENG An-chun. Progress in Development of New-type Vaccines against Fowl Cholera[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2018, 49(11): 2317-2325.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.xmsyxb.com/CN/10.11843/j.issn.0366-6964.2018.11.003

https://www.xmsyxb.com/CN/Y2018/V49/I11/2317

参考文献

[1] HARPER M, BOYCE J D, ADLER B. Pasteurella multocida pathogenesis:125 years after Pasteur[J]. FEMS Microbiol Lett, 2006, 265(1):1-10.
[2] WILSON B A, HO M. Pasteurella multocida:from zoonosis to cellular microbiology[J]. Clin Microbiol Rev, 2013, 26(3):631-655.
[3] AKTORIES K, ORTH J H C, ORTH B. Pasteurella Multocida:Molecular Biology, Toxins and Infection[M]. Berlin, Heidelberg:Springer, 2012:39-51.
[4] HARPER M, COX A D, ADLER B,et al. Pasteurella multocida lipopolysaccharide:the long and the short of it[J]. Vet Microbiol, 2011, 153(1-2):109-115.
[5] ADLER, BULACH D, CHUNG J, et al. Candidate vaccine antigens and genes in Pasteurella multocide[J]. J Biotechnol, 1999, 73(2-3):83.
[6] PATTISON M, MCMULLIN P F, BRADBURY J M, et al. Poultry diseases[M]. Amsterdam, The Netherlands:Elsevier, 2008:149-154.
[7] DZIVA F, MUHAIRWA A P, BISGAARD M, et al. Diagnostic and typing options for investigating diseases associated with Pasteurella multocida[J]. Vet Microbiol, 2008, 128(1-2):1-22.
[8] HOPKINS B A, OLSON L R D.Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys[J]. Avian Dis, 1997, 41(2):317-325.
[9] BIERER B W, DERIEUX W T.Immunologic response of turkeys to an avirulent Pasteurella multocida vaccine in the drinking water.:2.
Duration of immunity[J]. Poult Sci, 1972, 51(4):1402-1408.
[10] HERTMAN I, MARKENSON J, MICHAEL A,et al. Attenuated live fowl cholera vaccine I. Development of vaccine strain M3G of Pasteurella multocida[J]. Avian Dis, 1979, 23(4):863-869.
[11] HOPKINS B A,HUANG T H M, OLSON L D. Differentiating turkey postvaccination isolants of Pasteurella multocida using arbitrarily primed polymerase chain reaction[J]. Avian Dise, 1998, 42(2):265-274.
[12] UZZAU S, MAROGNA G, LEORI G S,et al. Virulence attenuation and live vaccine potential of aroA, crp cdt cya, and plasmid-cured mutants of Salmonella enterica serovar Abortusovis in mice and sheep[J]. Infect Immun, 2005, 73(7):4302-4308.
[13] HOMCHAMPA P, STRUGNELL R A, ADLER B.Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida[J]. Vaccine, 1997, 15(2):203-208.
[14] SCOTT P C, MARKHAM J F, WHITHEAR K G.Safety and efficacy of two live Pasteurella multocida aro-A mutant vaccines in chickens[J]. Avian Dise, 1999, 43(1):83-88.
[15] CHUNG J Y, WILKIE I, BOYCE J D,et al. Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A[J]. Infect Immun, 2001, 69(4):2487-2492.
[16] CHUNG J Y, WILKIE I, BOYCE J D,et al. Vaccination against fowl cholera with acapsular Pasteurella multocida A:1[J]. Vaccine, 2005, 23(21):2751-2755.
[17] 王林柏,孙久鹤,郭东春,等. 国内部分地区多杀性巴氏杆菌荚膜血清型和基因型的研究[J]. 中国预防兽医学报, 2016, 38(2):116-119.
WANG L B, SUN J H, GUO D C, et al. Identification of capsule serotype and genotype ofPasteurella multocida in some areas of China[J]. Chinese Journal of Preventive Veterinary Medicine, 2016, 38(2):116-119. (in Chinese)
[18] 吾鲁木汗·那孜尔别克,张宇凤,龚凤娟,等. 禽多杀性巴氏杆菌C48-3株hexABC基因缺失株的构建及其生物学特性分析[J]. 中国预防兽医学报, 2012, 34(8):597-601.
WULUMUHAN·NAZIERBIEKE, ZHANG Y F, GONG F J, et al. Construction and characterization of the hexABC gene deletion mutant of avian Pasteurella multocida C48-3[J]. Chinese Journal of Preventive Veterinary Medicine, 2012, 34(8):597-601. (in Chinese)
[19] HARPER M, COX A, ST MICHAEL F,et al. Decoration of Pasteurella multocida lipopolysaccharide with phosphocholine is important for virulence[J]. J Bacteriol, 2007, 189(20):7384-7391.
[20] BOYCE J D, HARPER M, ST MICHAEL F, et al. Identification of novel glycosyltransferases required for assembly of the Pasteurella multocida A:1 lipopolysaccharide and their involvement in virulence[J]. Infect Immun, 2009, 77(4):1532-1542.
[21] HARPER M, JOHN M, EDMUNDS M,et al. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure[J]. Vaccine, 2016, 34(14):1696-1703.
[22] GOSSET G, ZHANG Z G, NAYYAR S, et al. Transcriptome analysis of Crp-dependent catabolite control of gene expression in Escherichia coli[J]. J Bacteriol, 2004, 186(11):3516-3524.
[23] CHARLES R C, HARRIS J B, CHASE M R, et al. Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium[J]. PLoS One, 2009, 4(9):e6994.
[24] XIAO K P, LIU Q, LIU X Y, et al. Identification of the avian Pasteurella multocida phoP gene and evaluation of the effects of phoP deletion on virulence and immunogenicity[J]. Int J Mol Sci, 2015, 17(1):12.
[25] ZHAO X X, LIU Q, XIAO K P, et al. Identification of the crp gene in avian Pasteurella multocida and evaluation of the effects of crp deletion on its phenotype, virulence and immunogenicity[J]. BMC Microbiol, 2016, 16(1):125.
[26] STEEN J A, STEEN J A, HARRISON P, et al. Fis is essential for capsule production in Pasteurella multocida and regulates expression of other important virulence factors[J]. PLoS Pathog, 2010, 6(2):e1000750.
[27] MÉGROZ M, KLEIFELD O, WRIGHT A, et al. The RNA-binding chaperone Hfq is an important global regulator of gene expression in Pasteurella multocida and plays a crucial role in production of a number of virulence factors, including hyaluronic acid capsule[J]. Infect Immun, 2016, 84(5):1361-1370.
[28] BORDING A, NYMARK K, SMIDT E. Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs[J]. Acta Vet Scand, 1994, 35(2):155-163.
[29] WU J R, SHIEN J H, SHIEH H K,et al. Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE)[J]. Vaccine, 2007, 25(21):4140-4148.
[30] HATFALUDI T, AL-HASANIK, GONG L, et al. Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE[J]. PLoS One, 2012, 7(7):e39973.
[31] 王红勋. 禽多杀性巴氏杆菌PlpB基因克隆、表达及表达蛋白生物学特性研究[D]. 武汉:华中农业大学, 2007.
WANG H X. Cloning and expression the PlpB gene of Pasteurellla multocida and biological characterization of the expressing proteins[D]. Wuhan:Huazhong Agricultural University, 2007. (in Chinese)
[32] HATFALUDI T, AL-HASANI K, BOYCE J D, et al. Outer membrane proteins of Pasteurella multocida[J]. Vet Microbiol, 2010, 144(1-2):1-17.
[33] DABO S M, CONFER A, MONTELONGO M,et al. Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice[J]. Vaccine, 2008, 26(34):4345-4351.
[34] LEE J, KIM Y B, KWON M.Outer membrane protein H for protective immunity against Pasteurella multocida[J]. J Microbiol, 2007, 45(2):179-184.
[35] LUO Y, GLISSON J R, JACKWOOD M W,et al. Cloning and characterization of the major outer membrane protein gene (ompH) of Pasteurella multocida X-73[J]. J Bacteriol, 1997, 179(24):7856-7864.
[36] 曹素芳,黄青云. 禽多杀性巴氏杆菌C_48-1成熟外膜蛋白H重组亚单位疫苗免疫效果的研究[J]. 中国兽医科学, 2006, 36(6):464-467.
CAO S F, HUANG Q Y. Studies on immune efficacy of recombinant subunit vaccine with mature outer membrane protein H against avian Pasteurella multocida C_48-1[J]. Veterinary Science in China, 2006, 36(6):464-467. (in Chinese)
[37] STHITMATEE N, NUMEE S, KAWAMOTO E,et al. Protection of chickens from fowl cholera by vaccination with recombinant adhesive protein of Pasteurella multocida[J]. Vaccine, 2008, 26(19):2398-2407.
[38] THANASARASAKULPONG A, POOLPERM P, TANGJITJAROEN W,et al. Comparison of the effect of two purification methods on the immunogenicity of recombinant outer membrane protein H of Pasteurella multocida serovar A:1[J]. Vet Med Int, 2016, 2016:2579345.
[39] VARINRAK T, POOLPERM P, SAWADA T, et al. Cross-protection conferred by immunization with an rOmpH-based intranasal fowl cholera vaccine[J]. Avian Pathol, 2017, 46(5):515-525.
[40] HERATH C, KUMAR P, SINGH M,et al. Experimental iron-inactivated Pasteurella multocida A:1 vaccine adjuvanted with bacterial DNA is safe and protects chickens from fowl cholera[J]. Vaccine, 2010, 28(11):2284-2289.
[41] ALI H A, SAWADA T, NODA K.Protectivity of an immunoaffinity-purified 39 kDa capsular protein of avian Pasteurella multocida in mice[J]. J Vet Med Sci, 2004, 66(12):1603-1604.
[42] ALI H A H, SAWADA T, HATAKEYAMA H, et al. Characterization of a 39 kDa capsular protein of avian Pasteurella multocida using monoclonal antibodies[J]. Vet Microbiol, 2004, 100(1-2):43-53.
[43] STHITMATEE N, YANO T, LAMPANG K N, et al. A 39-kDa capsular protein is a major cross-protection factor as demonstrated by protection of chickens with a live attenuated Pasteurella multocida strain of P-1059[J]. J Vet Med Sci, 2013, 75(7):923-928.
[44] 恩特马克·布拉提白,彭清忠,严芳,等. 禽多杀性巴氏杆菌粘附蛋白Cp39的交叉免疫保护作用[J]. 微生物学报, 2010, 50(3):360-366.
BORRATHYBAY E, PENG Q Z,YAN F, et al. Cross-protective effect of the Cp39 adhesive proteins against avian Pasteurella multicida in mice[J]. Acta Microbiologica Sinica, 2010, 50(3):360-366. (in Chinese)
[45] 吾鲁木汗·那孜尔别克,彭清忠,何翠,等. 禽巴氏杆菌C_48-3株成熟黏附蛋白基因cpm39的克隆及序列分析[J]. 生物技术通讯, 2008, 19(1):17-19.
NAZIERBIEKE U, PENG Q Z, HE C,et al. Cloning and sequencing of a mature adhesive protein gene cpm39 of avian Pasteurella multocida C_48-3[J]. Letters in Biotechnology, 2008, 19(1):17-19. (in Chinese)
[46] BORRATHYBAY E, SAWADA T, KATAOKA Y, et al. A 39 kDa protein mediates adhesion of avian Pasteurella multocida to chicken embryo fibroblast cells[J]. Vet Microbiol, 2003, 97(3-4):229-243.
[47] TATUM F M, TABATABAI L B, BRIGGS R E.Protection against fowl cholera conferred by vaccination with recombinant Pasteurella multocida filamentous hemagglutinin peptides[J]. Avian Dis, 2009, 53(2):169-174.
[48] TATUM F M, TABATABAI L B, BRIGGS R E.Cross protection against fowl cholera disease with the use of recombinant Pasteurella multocida FHAB2 peptides vaccine[J]. Avian Dis, 2012, 56(3):589-591.
[49] SELLYEI B, BÁNYAI K, MAGYAR T. Characterization of the ptfA gene of avian Pasteurella multocida strains by allele-specific polymerase chain reaction[J]. J Vet Diagn Invest, 2010, 22(4):607-610.
[50] VARGA Z, VOLOKHOV D V, STIPKOVITS L, et al. Characterization of Pasteurella multocida strains isolated from geese[J]. Vet Microbiol, 2013, 163(1-2):149-156.
[51] GONG Q, QU N, NIU M F, et al. Evaluation of immunogenicity and protective efficacy of recombinant ptfA of avian Pasteurella multocida[J]. Iran J Vet Res, 2016, 17(2):84-88.
[52] GONG Q, CHENG M, NIU M F.Out membrane protein DNA vaccines for protective immunity against virulent avian Pasteurella multocida in chickens[J]. Proc Environ Sci, 2011, 8:723-729.
[53] GONG Q, QU N, NIU M F, et al. Immune responses and protective efficacy of a novel DNA vaccine encoding outer membrane protein of avian Pasteurella multocida[J]. Vet Immunol Immunopathol, 2013, 152(3-4):317-324.
[54] OKAY S, ÖZCENGIZ E, ÖZCENGIZ G. Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice[J]. Acta Microbiol Immunol Hung, 2012, 59(4):485-498.
[55] 曹素芳,黄青云,韩先干,等. 禽多杀性巴氏杆菌C_48-1外膜蛋白H基因真核表达载体的构建[J]. 中国兽医科技, 2005, 35(2):117-120.
CAO S F, HUANG Q Y, HAN X G, et al. Construction of eukaryotic expression vector of outer membrane protein H gene of avian Pasteurella multocida C_48-1[J]. Chinese Journal of Veterinary Science and Technology, 2005, 35(2):117-120. (in Chinese)